Excelsior Biopharma Inc. (TPEX:6496)
Taiwan · Delayed Price · Currency is TWD 26.75
+0.30 (1.13%)
Aug 6, 2025, 1:24 PM CST
Ligand Pharmaceuticals Market Cap
Excelsior Biopharma has a market cap or net worth of 1.24 billion as of August 5, 2025. Its market cap has decreased by -20.24% in one year.
Market Cap
1.24B
Enterprise Value
1.46B
Revenue
881.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
$26.75
Market Cap Chart
Since December 23, 2014, Excelsior Biopharma's market cap has decreased from 2.86B to 1.24B, a decrease of -56.83%. That is a compound annual growth rate of -7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 1.24B | -12.09% |
| Dec 31, 2024 | 1.41B | 3.69% |
| Dec 29, 2023 | 1.36B | 4.50% |
| Dec 30, 2022 | 1.30B | -4.79% |
| Dec 30, 2021 | 1.36B | -1.48% |
| Dec 31, 2020 | 1.38B | -16.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 187.67B |
| PharmaEssentia | 169.63B |
| Bora Pharmaceuticals Co., LTD. | 87.49B |
| Lotus Pharmaceutical | 58.76B |
| Oneness Biotech | 32.95B |
| Polaris Group | 28.51B |
| Center Laboratories | 27.64B |
| Pegavision | 25.04B |